Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 6/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.38 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.38 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.38 |
| ▸ | PTGIR | P43119 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22632071 | 0.90 | PPARA (0.54) | PPARAPPARGCNR1CNR2PTGIR | |
| SCHEMBL18794618 | 0.81 | PPARA (0.59) | PPARAPPARGCNR1CNR2PTGIR | |
| SCHEMBL17465386 | 0.80 | PPARA (0.49) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL29983667 | 0.78 | ALDH1A1 (0.50) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL22610063 | 0.78 | ALDH1A1 (0.50) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL17263526 | 0.78 | ALDH1A1 (0.50) | PPARAPPARGEP300KAT2BKAT5 | |
| SCHEMBL16984604 | 0.76 | PPARA (0.51) | PPARAPPARGCNR1FAAHEPHX2 | |
| SCHEMBL17465385 | 0.75 | PPARA (0.49) | PPARAPPARGCNR1PTGIRCYP2D6 | |
| SCHEMBL4449661 | 0.73 | PPARA (0.55) | PPARAPPARGCNR1EP300KAT2B | |
| SCHEMBL26430086 | 0.73 | PPARA (0.55) | PPARAPPARGCNR1EP300KAT2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | THE UNIVERSITY OF AKRON | 2020-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200347001-A1 | Synthesis of Bio-Based Polyols from Epoxidized Cardanol and Epoxidized Triglyceride by Using Thiol-Containing Reagents | GSTO1, FDFT1, DGAT2 | PPARA 811/4885PPARG 981/4885CNR1 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.